3476
R. J. Abdel-Jalil et al. / Tetrahedron Letters 45 (2004) 3475–3476
O
O
O
N
NH2
NH2
NH
ii
i
NH2
N
R
1
3a-g
2a-g
R
e
g
No.
R.
d
b
c
a
f
p-OCH3C6H4
p-ClC6H4
C6H5
Me
Bu
O
S
Scheme 1. Reagents and conditions: (i) RCHO, EtOH, 70 °C, 3 h; (ii) CuCl2, EtOH, 70 °C, 3 h.
5. Lyle, F. R. U.S. Patent 5,973,257, 1985; Chem. Abstr.
1985, 65, 2870.
6. Armarego, W. L. F. Adv. Heterocycl. Chem. 1979, 24,
1–62.
salt, and extend this principle of reaction for the
straightforward access to other heterocyclic systems.
7. Segarra, V.; Crespo, M. I.; Pujol, F.; Belata, J.; Domen-
ech, T.; Miralpeix, M.; Palacios, J. M.; Castro, A.;
Martinez, A. Bioorg. Med. Chem. Lett. 1998, 505–510.
8. Akazome, M.; Yamamoto, J.; Kondo, T.; Watanabe, Y.
J. Organomet. Chem. 1995, 494, 229–233.
9. Lopez, S. E.; Rosales, M. E.; Urdaneta, N.; Gody, M. V.;
Charris, J. E. J. Chem. Res. (S) 2000, 6, 258–259.
10. (a) Deepthi, K. S.; Reddy, D. S.; Reddy, P. P.; Reddy, P.
S. N. Indian J. Chem., Sect. B 2000, 39, 220–222; (b)
Naleway, J. J.; Fox, C. M. J.; Robinhold, D.; Terpets-
ching, E.; Olsen, N. A.; Haugland, R. P. Tetrahedron Lett.
1994, 46, 8569–8572.
Acknowledgements
We would like to thank Dr. Monther Khnafar and Mr.
Ehab El-Moumany for the assistance with the NMR
experiments. Financial support, provided by the Hash-
emite University, is greatly acknowledged. We express
€
€
our gratitude to Internationales Buro of BMBF, Julich,
for a fellowship granted to Dr. R. J. A.-J.
11. General procedure for quinazolinone: A mixture of anthra-
nilimide (3 mmol), CuCl2 (3 mmol) and the appropriate
aldehyde (3.3 mmol) in ethanol (10 mL) was refluxed for
2–3 h. The reaction mixture was then allowed to cool to rt,
the solvent was removed in vacuo, and the crude product
was purified by column chromatography over silica gel to
provide pure quinazolinone in high yields (Table 1).
Selected data; compound 2g (intermediate 2g was purified
by column chromatography for spectroscopic analysis): off
white prisms, mp 162–164 °C (from ethanol), EI-MS; m=z
References and notes
1. (a) Wolfe, J. F.; Rathman, T. L.; Sleevi, M. C.; Campbell,
J. A.; Greenwood, T. D. J. Med. Chem. 1990, 33, 161–166;
(b) Padia, J. K.; Field, M.; Hinton, J.; Meecham, K.;
Pablo, J.; Pinnock, R.; Roth, B. D.; Singh, L.; Suman-
Chauhan, N.; Trivedi, B. K.; Webdale, L. J. Med. Chem.
1998, 41, 1042–1049; (c) Khilil, M. A.; Soliman, R.;
Farghaly, A. M.; Bekhit, A. A. Arch. Pharm. 1994, 327,
27–30.
2. Xia, Y.; Yang, Z. Y.; Hour, M. J.; Kuo, S. C.; Xia, P.;
Bastow, K. F.; Nakanishi, Y.; Nampoothiri, P.; Hackl, T.;
Hamel, E.; Lee, K. H. Bioorg. Med. Chem. Lett. 2001, 11,
1193–1196.
3. Kenichi, O.; Yoshihisa, Y.; Toyonari, O.; Toru, I.;
Yoshio, I. J. Med. Chem. 1985, 28, 568–576.
4. Buchanan, J. G.; Sable, H. Z. In Selective Organic
Transformations; Thyagarajan, B. S., Ed.; Wiley-Inter-
science: New York, 1972; Vol. 2, pp 1–95.
1
212, H NMR (250 MHz, DMSO-d6) d: 5.82(s, 1H, NH),
6.3 (br d, 1H, furyl), 6.43 (s, 1H, NH), 6.75 (m, 2H, furyl),
7.29, 7.67 (m, m, 2H, 2H, phenyl), 8.50 (s, 1H, N@CH);
13C NMR (250 MHz, DMSO-d6) d: 105.7, 108.9, 113.5,
115.8, 125.9, 131.9, 141.3, 145.7, 153.1, 161.9. Compound
1
3g: off white prisms, mp 218–220 °C, EI-MS; m=z 212, H
NMR (250 MHz, DMSO-d6) d: 6.98 (dd, 1.0, 2.3 Hz, 1H,
furyl), 7.70–8.38 (m, 6H, phenyl+furyl), 12.76 (s, 1H, NH);
13C NMR (250 MHz, DMSO-d6) d: 112.0, 114.0,
120.6, 125.4, 125.9, 126.7, 134.1, 143.5, 145.5, 146.1,
148.1, 161.0.